Analyze Diet
Journal of veterinary pharmacology and therapeutics2022; 45(4); 409-414; doi: 10.1111/jvp.13053

Concentration of amikacin sulphate in synovial fluid when given in combination with dexamethasone phosphate in intravenous regional limb perfusion in standing horses.

Abstract: Eight horses underwent IVRLP at two occasions through a 23-gauge 2 cm long butterfly catheter. Regional anaesthesia of the ulnar, median and medial cutaneous antebrachial nerves was performed prior, and an 8 cm rubber tourniquet was placed on the proximal radius for 30 minutes following the infusion. The first infusion consisted of 2 g of amikacin sulphate and 10 mg of dexamethasone phosphate diluted with 0.9% NaCl to a total volume of 100 ml. The second perfusion was performed after a 2-week washout period, the same protocol was used but without dexamethasone phosphate. Synovial fluid samples were collected from the metacarpophalangeal joint at T = 0, 0.5, 2, 12, 24 and 36 h post-infusion. Synovial fluid amikacin sulphate concentrations were determined by use of liquid chromatography/tandem mass-spectrometry. All horses (n = 8) remained healthy throughout the study, and no adverse effects associated with the study were encountered. No statistically significant differences were found in synovial fluid amikacin sulphate concentrations between the treatment and the control group at any of the time points. In conclusion, dexamethasone phosphate can be used in IVRLP concomitantly with amikacin sulphate in cases of distal limb inflammation and pain without decreasing the synovial fluid concentration of amikacin sulphate.
Publication Date: 2022-03-20 PubMed ID: 35307838DOI: 10.1111/jvp.13053Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research was conducted to determine if the joint fluid (synovial fluid) concentrations of Amikacin Sulfate, an antibiotic, would be affected when given in conjunction with Dexamethasone Phosphate, a steroidal anti-inflammatory drug, through a procedure known as intravenous regional limb perfusion (IVRLP) in horses. The results indicated no significant reduction in the concentration of Amikacin Sulfate in the synovial fluid when used with Dexamethasone Phosphate.

Experiment Design and Methodology

  • The experiment involved eight horses that went through an IVRLP procedure twice.
  • Each IVRLP was facilitated using a 23-gauge 2 cm long butterfly catheter.
  • Before every IVRLP procedure, the horses were anaesthetised in the ulnar, median and medial cutaneous antebrachial nerves.
  • An 8 cm rubber tourniquet was placed on the proximal radius for 30 minutes following the infusion, in order to restrict the flow of the solutions in the body.
  • For the first infusion, a mixture of 2 g of amikacin sulphate and 10 mg of dexamethasone phosphate was used. The mixture was diluted using 0.9% NaCl to a total volume of 100 ml.
  • After a 2-week washout period, the same procedure was performed for a second time, this time without including dexamethasone phosphate.

Sample Collection and Analysis

  • Synovial fluid samples were collected from the horses’ metacarpophalangeal joint at six time points: immediately after the infusion (T=0), and at 0.5 hrs., 2 hrs., 12 hrs., 24 hrs., and 36 hrs. post-infusion.
  • The samples were then subjected to liquid chromatography/tandem mass-spectrometry to determine the concentration of amikacin sulphate in the synovial fluid.
  • No adverse effects were observed in any of the horses throughout the study, indicating the procedures were safe.

Research Findings

  • The analysis revealed that there was no statistically significant difference in the concentrations of amikacin sulphate in the synovial fluid between the first group (that received both amikacin sulphate and dexamethasone phosphate) and the second group (that received only amikacin).
  • These results led to the conclusion that dexamethasone phosphate can be used together with amikacin sulphate in cases of distal limb inflammation and pain in horses, without affecting the concentration of amikacin sulphate in the synovial fluid.

Cite This Article

APA
Gustafsson K, Tatz AJ, Britzi M, Dahan R, Sutton GA, Kelmer G. (2022). Concentration of amikacin sulphate in synovial fluid when given in combination with dexamethasone phosphate in intravenous regional limb perfusion in standing horses. J Vet Pharmacol Ther, 45(4), 409-414. https://doi.org/10.1111/jvp.13053

Publication

ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 45
Issue: 4
Pages: 409-414

Researcher Affiliations

Gustafsson, Kajsa
  • Department of Large Animal Medicine and Surgery, Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.
Tatz, Amos J
  • Department of Large Animal Medicine and Surgery, Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.
Britzi, Malka
  • National Residue Control Laboratory, Kimron Veterinary Institute, Beit Dagan, Israel.
Dahan, Roee
  • Department of Large Animal Medicine and Surgery, Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.
Sutton, Gila A
  • Department of Large Animal Medicine and Surgery, Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.
Kelmer, Gal
  • Department of Large Animal Medicine and Surgery, Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.

MeSH Terms

  • Amikacin / analysis
  • Amikacin / chemistry
  • Animals
  • Anti-Bacterial Agents / analysis
  • Dexamethasone / analogs & derivatives
  • Forelimb
  • Horses
  • Perfusion / veterinary
  • Synovial Fluid / chemistry

Grant Funding

  • Internal hospital grant

References

This article includes 23 references
  1. Beccar-Varela A, Epstein K, White C. Effect of experimentally induced synovitis on amikacin concentrations after intravenous regional limb perfusion. Veterinary Surgery 40(7), 891-897, 2011.
  2. Boff D, Crijns H, Teixeira M, Amaral F, Proost P. Neutrophils: Beneficial and harmful cells in septic arthritis. International Journal of Molecular Sciences 19(2), 468, 2018.
    doi: 10.3390/ijms19020468google scholar: lookup
  3. Cousty M, David Stack J, Tricaud C, David F. Effect of arthroscopic lavage and repeated intra-articular administrations of antibiotic in adult horses and foals with septic arthritis. Veterinary Surgery 46(7), 1008-1016, 2017.
    doi: 10.1111/vsu.12696google scholar: lookup
  4. Fogel I, Amir J, Bar-On E, Harel L. Dexamethasone therapy for septic arthritis in children. Pediatrics 136(4), X11, 2015.
  5. Gustafsson K, Tatz A, Dahan R, Britzi M, Soback S, Sutton G, Kelmer G. Time to peak concentration of amikacin in the antebrachiocarpal joint following cephalic intravenous regional limb perfusion in standing horses. Veterinary and Comparative Orthopaedics and Traumatology 33(05), 327-332, 2020.
    doi: 10.1055/s-0040-1714418google scholar: lookup
  6. Harvey A, Kilcoyne I, Byrne B, Nieto J. Effect of dose on intra-articular amikacin sulfate concentrations following intravenous regional limb perfusion in horses. Veterinary Surgery 45(8), 1077-1082, 2016.
    doi: 10.1111/vsu.12564google scholar: lookup
  7. Hui W, Rowan A, Richards C, Cawston T. Oncostatin M in combination with tumor necrosis factor? Induces cartilage damage and matrix metalloproteinase expression in vitro and In Vivo. Arthritis & Rheumatism 48(12), 3404-3418, 2003.
    doi: 10.1002/art.11333google scholar: lookup
  8. Kelmer G. Regional limb perfusion in horses. Veterinary Record 178(23), 581-584, 2016.
    doi: 10.1136/vr.i3082google scholar: lookup
  9. Kelmer G, Bell G, Martin-Jiminez T, Saxton A, Catasus C, Elliot S, Meibohm B. Evaluation of regional limb perfusion with amikacin using the saphenous, cephalic, and palmar digital veins in standing horses. Journal of Veterinary Pharmacology and Therapeutics 36(3), 236-240, 2012.
  10. Kilcoyne I, Nieto JE, Knych HK, Dechant JE. Time required to achieve maximum concentration of amikacin in synovial fluid of the distal interphalangeal joint after intravenous regional limb perfusion in horses. American Journal of Veterinary Research 79(3), 282-286, 2018.
    doi: 10.2460/ajvr.79.3.282google scholar: lookup
  11. Lapointe J, Laverty S, Lavoie J. Septic arthritis in 15 standardbred racehorses after intra-articular injection. Equine Veterinary Journal 24(6), 430-434, 1992.
  12. McGowan C, Cooper D, Ireland J. No Evidence that therapeutic systemic corticosteroid administration is associated with laminitis in adult horses without underlying endocrine or severe systemic disease. Veterinary Evidence 1(1), 2016.
    doi: 10.18849/ve.v1i1.12google scholar: lookup
  13. Meijer M, Weeren P, Rijkenhuizen A. Clinical experiences of treating septic arthritis in the equine by repeated joint lavage: a series of 39 cases. Journal of Veterinary Medicine Series A 47(6), 351-365, 2000.
  14. Moore R, Schneider R, Kowalski J, Bramlage L, Mecklenburg L, Kohn C. Antimicrobial susceptibility of bacterial isolates from 233 horses with musculoskeletal infection during 1979-1989. Equine Veterinary Journal 24(6), 450-456, 1992.
  15. Morton A. Diagnosis and treatment of septic arthritis. Veterinary Clinics of North America: Equine Practice 21(3), 627-649, 2005.
  16. Oreff G, Dahan R, Tatz A, Raz T, Britzi M, Kelmer G. The effect of perfusate volume on amikacin concentration in the metacarpophalangeal joint following cephalic regional limb perfusion in standing horses. Veterinary Surgery 45(5), 625-630, 2016.
    doi: 10.1111/vsu.12490google scholar: lookup
  17. Richardson D, Ahern B. Synovial and osseous infections. Equine Surgery 1189-1201, 2012.
  18. Richardson D, Dodge G. Dose-dependent effects of corticosteroids on the expression of matrix-related genes in normal and cytokine-treated articular chondrocytes. Inflammation Research 52(1), 39-49, 2003.
    doi: 10.1007/s000110300012google scholar: lookup
  19. Samona J, Cook C, Krupa K, Swatsell K, Jackson A, Dukes C, Martin S. Effect of intraoperative dexamethasone on pain scores and narcotic consumption in patients undergoing total knee arthroplasty. Orthopaedic Surgery 9(1), 110-114, 2017.
    doi: 10.1111/os.12313google scholar: lookup
  20. Schmal H, Bernstein A, Feucht M, Erdle B, Pestka J, Pham T, Kubosch E. Prospective clinical trial for septic arthritis: Cartilage degradation and inflammation are associated with upregulation of cartilage metabolites. Mediators of Inflammation 2016, 1-7.
  21. Southwood LL, Baxter GM, Fehr JE. How to perform arthrocentesis of the fetlock joint by using a distal palmar (plantar) approach. American Association of Equine Practitioners 43, 151-153, 1997.
  22. Taylor A, Mair T, Smith L, Perkins J. Bacterial culture of septic synovial structures of horses: does a positive bacterial culture influence prognosis?. Equine Veterinary Journal 42(3), 213-218, 2010.
    doi: 10.2746/042516409x480403google scholar: lookup
  23. Wereszka M, White N, Furr M. Factors associated with outcome following treatment of horses with septic tenosynovitis: 51 cases (1986-2003). Journal of the American Veterinary Medical Association 230(8), 1195-1200, 2007.
    doi: 10.2460/javma.230.8.1195google scholar: lookup

Citations

This article has been cited 0 times.